已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Real-world analysis of cost, treatment patterns, and outcomes of patients with metastatic cutaneous squamous cell carcinoma in the US

医学 西妥昔单抗 内科学 卡铂 放射治疗 肿瘤科 化疗 顺铂 回顾性队列研究 癌症 结直肠癌
作者
Xue Song,Chieh-I Chen,Gerasimos Konidaris,Nicole M. Zimmerman,Emily Ruiz
出处
期刊:Expert Review of Pharmacoeconomics & Outcomes Research [Taylor & Francis]
卷期号:: 1-10
标识
DOI:10.1080/14737167.2023.2223982
摘要

Objectives To describe real-world characteristics and treatment patterns of patients with metastatic cutaneous squamous cell carcinoma (mCSCC).Methods This retrospective observational study used MarketScan Commercial and Medicare Supplemental claims databases (1/1/2013–7/31/2019). Adult patients with mCSCC who initiated non-immunotherapy systemic treatment (i.e. index event) between 1 January 2014 and 31 December 2018 were assessed for treatment patterns, all-cause and CSCC-related healthcare resource utilization, costs, and mortality .Results Overall, 207 patients were included in the study(mean age 64.8 years, 76.3% male), 59.4% had prior radiotherapy, and 58.9% had prior CSCC-related surgery. During follow-up, 75.8%, 51.7%, and 35.7% of patients received chemotherapy, radiotherapy, and targeted therapy as first-line treatment, respectively. Cisplatin (32.9%) and carboplatin (22.7%) were the most common chemotherapy agents, and cetuximab (32.4%) was the most common targeted therapy during the first-line.Probability of death (95% CI) at month 6, year 1, and year 2 was 24% (16–32%), 50% (40 − 59%), and 67% (56 − 75%), respectively. Average CSCC-related healthcare costs were $5,354 per person per month (PPPM), with outpatient costs being the major cost driver at 96.4% ($5,160 PPPM).Conclusion During 2014–2018, patients with mCSCC were commonly treated with cisplatin and cetuximab; prognosis was generally poor. These results indicate opportunity for new treatments to improve survival outcomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xiaoming完成签到 ,获得积分10
1秒前
1秒前
u149676发布了新的文献求助60
2秒前
3秒前
上官若男的应助被南歪歪采纳,获得10
4秒前
小童发布了新的文献求助10
4秒前
4秒前
4秒前
3921337477的应助被u249125采纳,获得60
7秒前
知野纪完成签到 ,获得积分10
7秒前
lelele发布了新的文献求助10
8秒前
8秒前
勤劳的星月完成签到,获得积分10
8秒前
9秒前
Vincent完成签到 ,获得积分10
9秒前
10秒前
研友_ana完成签到,获得积分10
10秒前
Phoebe发布了新的文献求助10
11秒前
11秒前
没毛的鱼完成签到,获得积分10
12秒前
123456完成签到,获得积分10
12秒前
奈特奶糖完成签到,获得积分10
12秒前
12秒前
赵涵发布了新的文献求助10
12秒前
Blue完成签到 ,获得积分10
13秒前
深情安青的应助被Marjan采纳,获得10
13秒前
华仔的应助被快乐的心情采纳,获得30
13秒前
15秒前
17秒前
小马甲的应助被TS采纳,获得10
17秒前
17秒前
人间理想发布了新的文献求助10
17秒前
ooo完成签到 ,获得积分10
18秒前
u249125发布了新的文献求助60
19秒前
Ava的应助被古德猫宁采纳,获得10
20秒前
20秒前
20秒前
自私的猫发布了新的文献求助10
21秒前
没毛的鱼发布了新的文献求助30
21秒前
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184686
求助须知:如何正确求助?哪些是违规求助? 9573640
关于积分的说明 21832630
捐赠科研通 7782020
什么是DOI,文献DOI怎么找? 3434404
关于科研通互助平台的介绍 2558513
邀请新用户注册赠送积分活动 2481010